The HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) is set to list on the London Stock Exchange, Borsa Italiana and Xetra with a total expense ratio (TER) of 0.75%.
Tracking the Indxx Advanced Life Sciences & Healthcare Thematic index, WELL will look to offer investors exposure to developed and emerging companies that are involved in the advanced life sciences and smart healthcare sector.
The index currently holds 88 securities with its top five holdings including Edwards Lifesciences, Intuitive Surgical, Regeneron Pharmaceuticals, Boston Scientific and Illumnina.
Anthony Ginsberg, founder and managing director of Gins Global, commented: “Healthcare advances over the past 100 years have dramatically increased human lifespans and reduced the risk of death from communicable diseases like malaria or influenza.
"Technology and healthcare are now combining to create a faster, safer and more personalised generation of diagnostics, treatments and medicines. We are excited to offer WELL with HANetf, providing exposure to the companies at the forefront of these developments."
Hector McNeil, co-Founder and co-CEO, HANetf, added: “Healthcare has been a core portfolio holding for decades, and with this new ETF, we go beyond ‘Big Pharma’ to capture the companies that are addressing the key healthcare and wellness challenges of our time. When it comes to healthcare, we hope all investors get WELL soon.”
BlackRock currently offer the only other healthcare innovation ETF in Europe. The €423m iShares Healthcae Innovation UCITS ETF, which tracks the iSTOXX FactSet Breakthrough Healthcare index.
This is the third ETF GinsGlobal has listed in Europe, all through HANetf. The previous two were launched last October, the HAN-GINS Cloud Technology UCITS ETF (SKYY) and HAN-GINS Global Innovative Technologies ETF (ITEK).
Earlier this week, Europe’s first Kuwait ETF was listed through HANetf, the KMEFIC FTSE Kuwait Equity UCITS ETF (KUW8). This latest ETF takes HANetf’s range to five.